Ascher, John A.

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 1,177

A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression

Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 1,054

Oxytocin induces maternal behavior in virgin female rats

Pedersen, C. A., Ascher, J. A., Monroe, Y. L., & Prange, A. J. (1982) · Science

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 770

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 498

Bupropion Hydrochloride in Attention Deficit Disorder with Hyperactivity

CONNERS, C. K., CASAT, C. D., GUALTIERI, C. T., WELLER, E., READER, M., REISS, A., WELLER, R. A., KHAYRALLAH, M., & ASCHER, J. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 342

A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression

Dunner, D. L., Zisook, S., Billow, A. A., Batey, S. R., Johnston, J. A., & Ascher, J. A. (1998) · The Journal of Clinical Psychiatry

Treatment of Major DepressionPharmacovigilance and Adverse Drug Reactions

Cited by 180

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 168

Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly

Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 150

Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression

Weihs, K. L., Houser, T. L., Batey, S. R., Ascher, J. A., Bolden-Watson, C., Donahue, R. M. J., & Metz, A. (2002) · Biological Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 65